Loading...
StocksRunner logo
 
  Overview  
 
  Earnings  
 
  Calendar  
 
  Headlines  
 
  Posts  
 
 
CME Group
215.02
-0.43%
 

CME Stock Analysis

 
 
CME

CME Group

Last Price
Change
215.02
 
-0.43%
 
 
 
 

Summary

  Login to display CME Group (CME) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

214.12

205.29

187.05

177.2

 
 
1m
3m
6m
1y
 
 

Strengths

Rewards

 Upgraded on attractively valued

Rewards

 Earnings are forecast to grow

 

Risk Analysis

Risk Analysis

 Trading above its fair value

Risk Analysis

 Insider selling during the past 3 months

 
 

Risk Level

 
Risk Level
LOW
HIGH
 

CME Group (CME) has Moderate Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Above analyst estimates

StocksRunner

 Earnings increase YoY

 
 

Rating

×
 

Rating

3.38
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

1.50
 

StocksRunner

 Insider selling during the past 3 months

 

Future

×
 

Future

3.60
 

StocksRunner

 Trading above its fair value

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
59%
50%
50%
40%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
59%
26%
Positive
Negative
16 out of 27
events present
7 out of 27
events present
 
 
Events Calendar
Click for more information
 
October
S
M
T
W
T
F
S
November
S
M
T
W
T
F
S
 
 
Earnings
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
5,347
5,019
4,690
+6.77%
 
 
Cost of Revenue
809
753
837
-1.69%
 
 
Gross Profit
4,539
4,266
3,853
+8.54%
 
 
Operating Expense
1,298
1,250
1,208
+3.66%
 
 
Operating Income
3,241
3,016
2,645
+10.69%
 
 
Net Interest Income
-160
-163
-167
-2.12%
 
 
Interest Expense
160
163
167
-2.12%
 
 
Other Income
894
637
895
-0.06%
 
 
EPS
8.39
7.41
7.30
+7.21%
 
 
Next Earnings Date: Feb 06, 2024
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Insider Selling
3 Weeks Ago
211.33
+1.10%
 
Strong Earnings
2 Month Ago
215.43
+0.63%
 
Strong Earnings
2 Month Ago
214.08
-0.08%
 
Buy Rating
2 Month Ago
219.38
-0.31%
 
Buy Rating
2 Month Ago
217.10
+0.47%
 
Top Headlines



















 
 
 
joker
 
 
 
StocksRunner

Explore our CME stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive CME Daily Alerts

Enter your email to receive daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
 
 
 

CME Stock Trading Analysis

 
 
 
 

Economic Data

 
 
 
 
Today
November 29
 
 
USA GDP Growth Rate
 

Actual

5.20%

Previous

2.10%

 
Tomorrow
November 30
 
 
USA Core PCE Price MoM
 

Previous

0.30%

Forecast

0.30%

USA Initial Jobless Claims
 

Previous

209K

Forecast

213K

USA Personal Income
 

Previous

0.30%

Forecast

0.30%

USA Personal Spending
 

Previous

0.70%

Forecast

0.40%

 
 
 
 

Stock Analysis and Insights

 
 
 
 
CME CME Group
Last Price
Change
215.02
 
-0.43%
 
 
 
  Overview  
 
  Earnings  
 
  Calendar  
 
  Headlines  
 
  Posts  
 

 
joker
 
 
 
 

Summary

  Login to display CME Group (CME) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

214.12

205.29

187.05

177.2

 
 
1m
3m
6m
1y
 
 

Strengths

Rewards

 Upgraded on attractively valued

Rewards

 Earnings are forecast to grow

 

Risk Analysis

Risk Analysis

 Trading above its fair value

Risk Analysis

 Insider selling during the past 3 months

 
 

Risk Level

 
Risk Level
LOW
HIGH
 

CME Group (CME) has Moderate Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Above analyst estimates

StocksRunner

 Earnings increase YoY

 
 

Rating

×
 

Rating

3.38
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

1.50
 

StocksRunner

 Insider selling during the past 3 months

 

Future

×
 

Future

3.60
 

StocksRunner

 Trading above its fair value

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
59%
50%
50%
40%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
59%
26%
Positive
Negative
16 out of 27
events present
7 out of 27
events present
 

 

Events Calendar

Hover for information

 
October
 
S
M
T
W
T
F
S
 
November
 
S
M
T
W
T
F
S
 
 
 
Earnings
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
5,347
5,019
4,690
+6.77%
 
 
Cost of Revenue
809
753
837
-1.69%
 
 
Gross Profit
4,539
4,266
3,853
+8.54%
 
 
Operating Expense
1,298
1,250
1,208
+3.66%
 
 
Operating Income
3,241
3,016
2,645
+10.69%
 
 
Net Interest Income
-160
-163
-167
-2.12%
 
 
Interest Expense
160
163
167
-2.12%
 
 
Other Income
894
637
895
-0.06%
 
 
EPS
8.39
7.41
7.30
+7.21%
 
 
Next Earnings Date: Feb 06, 2024
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Insider Selling
3 Weeks Ago
211.33
+1.10%
 
Strong Earnings
2 Month Ago
215.43
+0.63%
 
Strong Earnings
2 Month Ago
214.08
-0.08%
 
Buy Rating
2 Month Ago
219.38
-0.31%
 
Buy Rating
2 Month Ago
217.10
+0.47%
 
Top Headlines



















 
 
 
 
 

Market Overview

 
 
 

Based on 4,385 events Last updated Nov 29, 2023 12:39

 
StocksRunner
sentiment
28%
68%
Negative
Positive
 
Indicator
Health
  %

Market
 
    70%
 
Potential
 
    85%
 
Earnings
 
    77%
 
Momentum
 
    72%
 
Rating
 
    35%
 
 
 
 
 
 
 
StocksRunner

Discover CME stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of CME. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive CME Daily Alerts

Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CME stock trends

CME stock performance

CME Stock analysis

CME investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker